Related Experiment Video

Updated: Aug 30, 2026

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
10:24

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells

Published on: May 22, 2026

[Antituberculosis chemoprophylaxis in children]

Clemax C. Sant'Anna1, Solange G. David, Anna M. Marques

  • 1Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

Jornal De Pediatria
|December 3, 2003
PubMed

Insights

Antituberculosis chemoprophylaxis is a safe and effective way to prevent childhood tuberculosis. National guidelines and international trends support expanding its use in children to prevent infection progression.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis remains a significant global health concern, particularly in children.
  • Preventive strategies are crucial to reduce disease burden and transmission.
  • Current guidelines and emerging trends necessitate a review of childhood tuberculosis chemoprophylaxis.

Purpose of the Study:

  • To review current indications for antituberculosis chemoprophylaxis in childhood.
  • To align with Brazilian national guidelines and emerging consensus on tuberculosis control.
  • To inform policy and practice regarding pediatric tuberculosis prevention.

Main Methods:

  • Literature review of Medline-indexed articles.
  • Analysis of Brazilian Ministry of Health official publications.
  • Inclusion of recommendations from the Brazilian Consensus on Tuberculosis.

Main Results:

  • Antituberculosis chemoprophylaxis is demonstrated as an effective and safe preventive measure in childhood.
  • Chemoprophylaxis complements, rather than conflicts with, BCG vaccination by preventing infection progression.
  • Evidence supports the role of chemoprophylaxis in averting the development of active tuberculosis disease.

Conclusions:

  • International recommendations and recent Brazilian trends advocate for broader indications of chemoprophylaxis in children.
  • Expansion of chemoprophylaxis is needed to enhance tuberculosis prevention strategies in Brazil.
  • Policy adjustments are required to implement wider chemoprophylaxis use in pediatric populations.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...